Company Filing History:
Years Active: 2012-2013
Title: Yoon Jee Kim: Innovator in Calcium Channel Modulation
Introduction
Yoon Jee Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmacology, particularly in the development of calcium channel modulators. With a total of 2 patents, his work is paving the way for new therapeutic treatments.
Latest Patents
Yoon Jee Kim's latest patents include innovative compounds that serve as calcium channel modulators. The first patent, titled "Imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof," discloses novel imidazolylalkylcarbonyl derivatives that are useful in modulating calcium channels. This patent also outlines a method for treating diseases by administering these compounds based on their inhibitory activity against calcium channels.
The second patent, "Pyrazolylmethylamine compounds as calcium channel modulators and preparation method thereof," relates to pyrazolylmethylamine-piperazine derivatives and their pharmaceutically acceptable salts. These compounds are effective as calcium channel modulators, and the patent describes a method for manufacturing them, as well as their medicinal use in treating diseases due to their modulatory effects.
Career Highlights
Yoon Jee Kim is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development. His work focuses on creating innovative solutions that address critical health issues through the modulation of calcium channels.
Collaborations
Yoon Jee Kim collaborates with notable colleagues, including Kyung Il Choi and Ghilsoo Nam. Their combined expertise enhances the research efforts at the Korea Institute of Science and Technology.
Conclusion
Yoon Jee Kim is a key figure in the development of calcium channel modulators, with a focus on innovative compounds that have significant therapeutic potential. His contributions are vital to advancing medical treatments and improving patient outcomes.